Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells

Cancer Letters

Volumn 313, Issue 1, 2011, Pages 64-75

  Gogineni, Venkateswara Rao ^a   Nalla, Arun Kumar ^a   Gupta, Reshu ^a   Dinh, Dzung H ^a   Klopfenstein, Jeffrey D ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Chk2; G2 M cell cycle arrest; Meningioma; Radiotherapy

Indexed keywords

CHECKPOINT KINASE 2; CYCLIN B1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; PROTEIN CDC25C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT MENINGIOMA; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RADIOSENSITIVITY; UPAR GENE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; CARBANILIDES; CDC25 PHOSPHATASES; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL LINE, TUMOR; CYCLIN B; CYCLIN B1; G2 PHASE; HUMANS; MENINGIOMA; MICE; MICE, NUDE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054103500     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.08.022     Document Type: Article

References (54)

1. Alexiou G.A., Gogou P., Markoula S., Kyritsis A.P. Management of meningiomas. Clin. Neurol. Neurosurg. 2010, 112:177-182.
2. Norden A.D., Drappatz J., Wen P.Y. Advances in meningioma therapy. Curr. Neurol. Neurosci. Rep. 2009, 9:231-240.
3. Kondziolka D., Mathieu D., Lunsford L.D., Martin J.J., Madhok R., Niranjan A., Flickinger J.C. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 2008, 62:53-58.
4. Malik I., Rowe J.G., Walton L., Radatz M.W., Kemeny A.A. The use of stereotactic radiosurgery in the management of meningiomas. Br. J. Neurosurg. 2005, 19:13-20.
5. Milker-Zabel S., Zabel-du B.A., Huber P., Schlegel W., Debus J. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:858-863.
6. Colvett K.T., Hsu D.W., Su M., Lingood R.M., Pardo F.S. High PCNA index in meningiomas resistant to radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1997, 38:463-468.
7. Askoxylakis V., Zabel-du B.A., Schlegel W., Debus J., Huber P., Milker-Zabel S. Patterns of failure after stereotactic radiotherapy of intracranial meningioma. J. Neurooncol. 2010, 98:367-372.
8. Marucci G., Betts C.M., Frank G., Foschini M.P. Oncocytic meningioma: report of a case with progression after radiosurgery. Int. J. Surg. Pathol. 2007, 15:77-81.
9. Preston D.L., Ron E., Yonehara S., Kobuke T., Fujii H., Kishikawa M., Tokunaga M., Tokuoka S., Mabuchi K. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J. Natl. Cancer. Inst. 2002, 94:1555-1563.
10. Shintani T., Hayakawa N., Kamada N. High incidence of meningioma in survivors of Hiroshima. Lancet 1997, 349:1369.
11. Osipov V., Ho K.C., Krouwer H.G., Meyer G., Shidham V.B. Post-radiation dedifferentiation of meningioma into osteosarcoma. BMC Cancer 2002, 2:34.
12. Svajdler M., Bohus P., Rychly B., Sulla I., Moram M. Post-radiation dedifferentiation of meningioma into chondroblastic osteosarcoma. Cesk. Patol. 2009, 45:20-23.
13. Elledge S.J. Cell cycle checkpoints: preventing an identity crisis. Science 1996, 274:1664-1672.
14. Cann K.L., Hicks G.G. Regulation of the cellular DNA double-strand break response. Biochem. Cell Biol. 2007, 85:663-674.
15. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
16. Tamamoto T., Ohnishi K., Takahashi A., Wang X., Yosimura H., Ohishi H., Uchida H., Ohnishi T. Correlation between gamma-ray-induced G2 arrest and radioresistance in two human cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 1999, 44:905-909.
17. Aguirre-Ghiso J.A. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 2002, 21:2513-2524.
18. Vial E., Sahai E., Marshall C.J. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4:67-79.
19. Liu D., Aguirre-Ghiso J.A., Estrada Y., Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 2002, 1:445-457.
20. Kjoller L., Hall A. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J. Cell Biol. 2001, 152:1145-1157.
21. Koshelnick Y., Ehart M., Hufnagl P., Heinrich P.C., Binder B.R. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 1997, 272:28563-28567.
22. Lester R.D., Jo M., Montel V., Takimoto S., Gonias S.L. UPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J. Cell Biol. 2007, 178:425-436.
23. Vivas L., Chiaraviglio E. The effects of reversible lidocaine-induced lesion of the tissue surrounding the anterior ventral wall of the third ventricle on drinking in rats. Behav. Neural Biol. 1992, 57:124-130.
24. Lee W.H. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 1990, 27:389-395.
25. Baia G.S., Slocum A.L., Hyer J.D., Misra A., Sehati N., VandenBerg S.R., Feuerstein B.G., Deen D.F., McDermott M.W., Lal A. A genetic strategy to overcome the senescence of primary meningioma cell cultures. J. Neurooncol. 2006, 78:113-121.
26. Tsai J.C., Goldman C.K., Gillespie G.Y. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J. Neurosurg. 1995, 82:864-873.
27. Gondi C.S., Lakka S.S., Dinh D.H., Olivero W.C., Gujrati M., Rao J.S. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene 2004, 23:8486-8496.
28. Kargiotis O., Chetty C., Gogineni V., Gondi C.S., Pulukuri S.M., Kyritsis A.P., Gujrati M., Klopfenstein J.D., Dinh D.H., Rao J.S. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Int. J. Oncol. 2008, 33:937-947.
29. McCutcheon I.E., Friend K.E., Gerdes T.M., Zhang B.M., Wildrick D.M., Fuller G.N. Intracranial injection of human meningioma cells in athymic mice. An orthotopic model for meningioma growth. J. Neurosurg. 2000, 92:306-314.
30. Ragel B.T., Elam I.L., Gillespie D.L., Flynn J.R., Kelly D.A., Mabey D., Feng H., Couldwell W.T., Jensen R.L. A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation. J. Neurosurg. 2008, 108:304-310.
31. Gogineni V.R., Nalla A.K., Gupta R., Gorantla B., Gujrati M., Dinh D.H., Rao J.S. Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma. Int. J. Oncol. 2010, 36:809-816.
32. Momcilovic O., Choi S., Varum S., Bakkenist C., Schatten G., Navara C. Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G(2) but not G(1) cell cycle arrest in pluripotent human embryonic stem cells. Stem cells 2009, 27:1822-1835.
33. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., Mak T.W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000, 287:1824-1827.
34. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 2000, 33:261-274.
35. Kupersmith M.J., Warren F.A., Newall J., Ransohoff J. Irradiation of meningiomas of the intracranial anterior visual pathway. Ann. Neurol. 1987, 21:131-137.
36. Knizetova P., Darling J.L., Bartek J. Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy. J. Cell. Mol. Med. 2008, 12:111-125.
37. Umansky F., Shoshan Y., Rosenthal G., Fraifeld S., Spektor S. Radiation-induced meningioma. Neurosurg. Focus 2008, 24:E7.
38. Kim J.J., Tannock I.F. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat. Rev. Cancer 2005, 5:516-525.
39. Pietenpol J.A., Stewart Z.A. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 2002, 181-182:475-481.
40. DiPaola R.S. To arrest or not to G(2)-M Cell-cycle arrest: commentary re: A. K. Tyagi et al., Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G(2)-M arrest, and apoptosis. Clin. cancer res., 8: 3512-3519, 2002. Clin. Cancer Res. 2002, 8:3311-3314.
41. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., Elledge S.J. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 2000, 97:10389-10394.
42. Melchionna R., Chen X.B., Blasina A., McGowan C.H. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat. Cell Biol. 2000, 2:762-765.
43. Bartek J., Falck J., Lukas J. CHK2 kinase-a busy messenger. Nat. Rev. Mol. Cell Biol. 2001, 2:877-886.
44. Matsuoka S., Huang M., Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998, 282:1893-1897.
45. Rhind N., Russell P. Roles of the mitotic inhibitors Wee1 and Mik1 in the G(2) DNA damage and replication checkpoints. Mol. Cell Biol. 2001, 21:1499-1508.
46. Shieh S.Y., Ahn J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 2000, 14:289-300.
47. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
48. Taylor W.R., Stark G.R. Regulation of the G2/M transition by p53. Oncogene 2001, 20:1803-1815.
49. Lindqvist A., Rodriguez-Bravo V., Medema R.H. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J. Cell Biol. 2009, 185:193-202.
50. Gavet O., Pines J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev. Cell 2010, 18:533-543.
51. Timofeev O., Cizmecioglu O., Settele F., Kempf T., Hoffmann I. Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition. J. Biol. Chem. 2010, 285:16978-16990.
52. Ragno P. The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. Cell Mol. Life Sci. 2006, 63:1028-1037.
53. Chetty C., Lakka S.S., Bhoopathi P., Gondi C.S., Veeravalli K.K., Fassett D., Klopfenstein J.D., Dinh D.H., Gujrati M., Rao J.S. Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells. Mol. Cancer Ther. 2010, 9:2605-2617.
54. Gogineni V.R., Kargiotis O., Klopfenstein J.D., Gujrati M., Dinh D.H., Rao J.S. RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells. Int. J. Oncol. 2009, 34:209-218.